Thrivent Financial for Lutherans Cuts Position in Simulations Plus, Inc. (NASDAQ:SLP)

Thrivent Financial for Lutherans trimmed its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 4.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,272 shares of the technology company’s stock after selling 585 shares during the period. Thrivent Financial for Lutherans owned about 0.07% of Simulations Plus worth $645,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. EntryPoint Capital LLC purchased a new stake in shares of Simulations Plus during the first quarter valued at approximately $57,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Simulations Plus during the first quarter valued at about $70,000. Los Angeles Capital Management LLC acquired a new stake in shares of Simulations Plus during the second quarter valued at about $206,000. Arizona State Retirement System purchased a new stake in shares of Simulations Plus during the second quarter worth about $218,000. Finally, Connecticut Wealth Management LLC acquired a new position in shares of Simulations Plus in the first quarter worth about $204,000. 78.08% of the stock is owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $35.18, for a total value of $703,600.00. Following the transaction, the director now owns 3,501,592 shares in the company, valued at $123,186,006.56. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In the last three months, insiders have sold 60,750 shares of company stock worth $2,145,055. Corporate insiders own 20.90% of the company’s stock.

Analyst Ratings Changes

SLP has been the topic of several recent analyst reports. JMP Securities initiated coverage on shares of Simulations Plus in a report on Tuesday, July 16th. They issued a “market perform” rating on the stock. KeyCorp initiated coverage on Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target for the company. Oppenheimer upped their price objective on Simulations Plus from $55.00 to $65.00 and gave the company an “outperform” rating in a research note on Thursday, June 13th. Craig Hallum reiterated a “buy” rating and issued a $56.00 target price on shares of Simulations Plus in a research report on Wednesday, July 3rd. Finally, William Blair reissued an “outperform” rating on shares of Simulations Plus in a research report on Thursday, September 12th. One analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average target price of $56.00.

Simulations Plus Trading Up 1.2 %

Shares of NASDAQ SLP opened at $30.19 on Wednesday. The company has a market capitalization of $604.04 million, a price-to-earnings ratio of 62.90 and a beta of 0.69. Simulations Plus, Inc. has a twelve month low of $29.37 and a twelve month high of $51.22. The firm has a 50-day moving average of $34.42 and a two-hundred day moving average of $41.54.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.